Skip to Main Content

Author Details

Rosalba Salcedo
Center for Cancer Research, National Cancer Institute
1990
45
28
PMIDPaper TitleJournal TitlePublished Year
35228752Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.Nat Med2022
34093543Expression of Nutrient Transporters on NK Cells During Murine Cytomegalovirus Infection Is MyD88-Dependent.Front Immunol2021
33497366Tristetraprolin expression by keratinocytes protects against skin carcinogenesis.JCI Insight2021
32841340Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation.Blood Adv2020
32589707Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation.Blood2020
30523076Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury.Science2019
31164412T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis.Mol Cancer Res2019
28142322Microbes and Cancer.Annu Rev Immunol2017
23027006Laser capture microdissection for protein and NanoString RNA analysis.Methods Mol Biol2013
24264989Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.Science2013
23660392MyD88 and its divergent toll in carcinogenesis.Trends Immunol2013
22571338High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discovery.Cancer Invest2012
23103862Resurrection of endogenous retroviruses in antibody-deficient mice.Nature2012
22719066The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma.Cancer Res2012
22908325IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis.J Exp Med2012
22837383Compartmentalized control of skin immunity by resident commensals.Science2012
19816523Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax.Cancer Gene Ther2010
20924115Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis.Cancer Res2010
20624890MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.J Exp Med2010
19258507Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.Cancer Res2009
19299733Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.J Immunol2009
16670342Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors.J Immunol2006
16531816Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors.J Immunother2006
15928303Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.J Natl Cancer Inst2005
15585838IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.J Immunol2004
12791666Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells.Blood2003
12912963Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.Clin Cancer Res2003
12851652Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses.Microcirculation2003
12473612Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1alpha.Clin Cancer Res2002
12171898Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts.Clin Cancer Res2002
11390513Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.J Immunol2001
11494048The diverse role of chemokines in tumor progression: prospects for intervention (Review).Int J Mol Med2001
10784615Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens.Int Immunol2000
10891427Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.Blood2000
11023990Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.FASEB J2000
10233851Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.Am J Pathol1999
9184072Endogenous fibronectin of blood polymorphonuclear leukocytes: immunochemical characterization and subcellular localization.Exp Cell Res1997
9184073Endogenous fibronectin of blood polymorphonuclear leukocytes: stimulus-induced secretion and proteolysis by cell surface-bound elastase.Exp Cell Res1997
8681941The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes.Eur J Biochem1996
9229375Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi.Parasite Immunol1996
7536632Constitutive alpha V beta 3 integrin-mediated adhesion of human lymphoid B cells to vitronectin substrate.Cell Immunol1995
1680199The Epstein-Barr virus BNLF-1 membrane protein LMP1 induces homotypic adhesion mediated by CD11a/CD18 in a murine B-cell line, mimicking the action of phorbol ester.J Virol1991
1709118ICAM-2 peptides mediate lymphocyte adhesion by binding to CD11a/CD18 and CD49d/CD29 integrins.FEBS Lett1991
2016518A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. Cellular distribution and molecular characterization of the antigen.J Immunol1991
1983073The pivotal role of the Leu-CAM and ICAM molecules in human leukocyte adhesion.Cell Differ Dev1990
  • 1 - 45 of 45

Recommended Authors

QIMR Berghofer Medical Research Institute
Career Start Year 2011
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
National Cancer Institute
Career Start Year 2007
Number of shared co-authors 5
University of Florida
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Center for Perinatal Research, Nationwide Children's Hospital
Career Start Year 1998
Number of shared co-authors 0
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 0
Dartmouth Geisel School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
CHU de Quebec Research Center
Career Start Year 1993
Number of shared co-authors 0
West Virginia University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
University of California Riverside
Career Start Year 1992
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 2
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 1
Raybiotech Co.
Career Start Year 1988
Number of shared co-authors 0
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
David Geffen School of Medicine at university of california los angeles
Career Start Year 1987
Number of shared co-authors 1
Institute of Pharmaceutical Sciences, ETH Zurich
Career Start Year 1986
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
University of Vienna
Career Start Year 1985
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute at Frederick
Career Start Year 1981
Number of shared co-authors 6
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 0
School of Medicine. University of Connecticut
Career Start Year 1977
Number of shared co-authors 0
Wihuri Research Institute
Career Start Year 1977
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 1

Collaborators

Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 14
Co-authored papers 7
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
National Institute of Allergy and Infectious Diseases
Co-authored papers 3
National Institute of Allergy and Infectious Diseases
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Institute of Allergy and Infectious Diseases
Co-authored papers 2
Center for Cancer Research
Co-authored papers 2
Louisiana State University
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
National Eye Institute, National Institutes of Health
Co-authored papers 1
National Institute of Arthritis, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Frederick National Laboratory for Cancer Research, Inc.
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Frederick National Laboratory for Cancer Research
Co-authored papers 1
Co-authored papers 1
University of California san francisco
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
The Arctic University of Norway
Co-authored papers 1